CoreWeave, Inc. reported that Chief Development Officer Brannin McBee and a set of related entities sold a combined $34.9 million of Class A Common Stock on March 9, 2026. The dispositions were carried out under a pre-arranged Rule 10b5-1 trading plan and occurred at prices between $71.72 and $74.32 per share.
The specific sales by McBee were recorded as follows: 89,646 shares at $71.7232, 141,108 shares at $72.4075, 18,163 shares at $73.7281, and 51,083 shares at $74.3245. Separate sales attributed to McBee’s spouse amounted to 15,294 shares at $71.7283, 23,303 shares at $72.4113, 2,909 shares at $73.7639, and 8,489 shares at $74.3217.
Additional related-party transactions on the same day included activity by the Brannin J. McBee 2022 Irrevocable Trust, for which McBee’s spouse is trustee, and the Canis Major 2025 GRAT, of which McBee is sole trustee and beneficiary. The trust sold 24,857 shares at $71.7283, 37,874 at $72.4113, 4,728 at $73.7640, and 13,796 at $74.3217. The Canis Major 2025 GRAT sold 15,295 shares at $71.7283, 23,302 shares at $72.4113, 2,910 at $73.7640, and 8,488 shares at $74.3217.
On the same date, several conversions of Class B Common Stock into Class A Common Stock were recorded. Brannin McBee converted 300,000 shares of Class B into Class A. His spouse converted 49,995 shares of Class B into Class A. The Brannin J. McBee 2022 Irrevocable Trust converted 81,255 shares of Class B into Class A, and the Canis Major 2025 GRAT converted 49,995 shares of Class B into Class A.
Following the March 9 sales, CoreWeave shares have risen to $81.96, which is roughly 10% higher than the range of sale prices. Despite that uptick, the stock remains well below its 52-week high of $187.
Context on valuation, performance and coverage
CoreWeave carries a reported enterprise valuation of $39.4 billion. Recent financial results show pronounced top-line expansion: fiscal year 2025 revenue was $5.13 billion, representing a 168% increase from the prior year. In the fourth quarter of 2025, the company posted revenue of $1.57 billion, a 15.2% increase versus the third quarter.
Market and sell-side sentiment around the company is mixed. H.C. Wainwright has reiterated a Buy rating, citing backlog growth and the emergence of new revenue streams as supportive. Bernstein initiated coverage with an Underperform rating, expressing concern about future market dynamics. Oppenheimer launched coverage with an Outperform rating, pointing to CoreWeave’s specialized GPU infrastructure for AI workloads as a competitive strength.
On the corporate partnership front, CoreWeave announced a multi-year strategic agreement with Perplexity to support AI inference workloads. The collaboration will leverage NVIDIA-powered clusters to power Perplexity’s Sonar and Search API ecosystem.
What the filings show
- All sales on March 9, 2026 were executed under a Rule 10b5-1 trading plan, indicating pre-arranged timing and terms.
- The sale prices ranged narrowly from $71.72 to $74.32 per share across multiple transactions and entities associated with McBee.
- Large conversions of Class B shares into Class A shares were executed the same day by McBee, his spouse, the family trust and the GRAT.
Implications and positioning
The transactions reflect material liquidity events for insiders and affiliated entities. At the same time, CoreWeave’s recent revenue trajectory and the set of divergent analyst ratings underscore the juxtaposition of rapid growth and differing views on future valuation and market dynamics. The partnership with Perplexity further emphasizes the company’s focus on specialized GPU infrastructure for AI inference.
Given the mix of strong revenue growth, varied sell-side assessments, and the insider sales executed under a 10b5-1 plan, investors and market participants will likely continue to weigh execution on demand for compute capacity against valuation expectations.